Immupharma (IMM.L) Performance Overview
- Price movement (24‑hour period ending 03:36 AM CET, 21 Oct 2026): +3.9 %
- Current trading price: GBX 4.10
- Shares outstanding: 6.3 million
- Market capitalization: GBX 35.4 million
- Volume (last 24 hours): GBX 7.9 million
- Year‑to‑date change (since last month end): +4.99 %
- 200‑day simple moving average: GBX 4.86
- 52‑week high: GBX 14.00 (10 Oct 2025)
- 52‑week low: GBX 3.10 (15 Sep 2026)
24‑Hour Performance of Related Stocks
| Symbol | 24‑Hour Change | Current Price | Market Capitalisation |
|---|---|---|---|
| GELN.L | +26.42 % | GBX 16.00 | GBX 40.5 million |
| PRO.L | –4.55 % | GBX 4.14 | GBX 42.4 million |
| BRES.L | +3.74 % | GBX 6.34 | GBX 40.4 million |
| KAV.L | 0 % | GBX 0.62 | GBX 41.0 million |
| EGT.L | 0 % | GBX 10.75 | GBX 39.6 million |
Company Profile
ImmuPharma PLC is a pharmaceutical company headquartered in London, United Kingdom. The firm focuses on research and development of treatments for conditions such as lupus, cancer, post‑operative pain, and highly resistant hospital‑acquired infections. ImmuPharma is listed on the London Stock Exchange and provides further information on its website: www.immupharma.com .